ArriVent BioPharma
Develops licensed oncology assets led by firmonertinib and antibody-drug conjugates.
$30.17
After-hours close−0.05 (−0.17%)
At close$30.22(−2.52%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 101.63%Insiders 1.12%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 46.57M · Float 29.78M · 63.9% free float
Institutions13F, as of Jun 30, 2026
166 holders · 47.33M shares · 39 new positions · 113 increased · 29 reduced · 16 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 4.52M | 9.70% | +114.4K | Aug 14, 2026 |
| Infinitum Asset Management, LLC | 4.44M | 9.53% | +289.5K | Aug 14, 2026 |
| HHLR Advisors, Ltd. | 3.93M | 8.44% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 3.25M | 6.98% | +720.1K | Aug 7, 2026 |
| Orbimed Advisors LLC | 3.03M | 6.50% | 0 | Aug 14, 2026 |
| FMR LLC | 2.78M | 5.97% | −237.2K | Aug 13, 2026 |
| Octagon Capital Advisors LP | 1.97M | 4.23% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 1.77M | 3.81% | +246.0K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Infinitum Asset Management, LLC | 9.90% | 4.12M | 13G | Feb 17, 2026 ↗ |
| Suvretta Capital Management, LLC | 9.90% | 3.41M | 13G | Aug 13, 2025 ↗ |
| Hillhouse Investment Management, Ltd. | 9.50% | 3.93M | 13G | Feb 17, 2026 ↗ |
| Orbimed Advisors LLCincl. OrbiMed Asia GP IV, L.P., OrbiMed Capital GP VIII LLC +1 more | 7.50% | 3.03M | 13D | Aug 13, 2025 ↗ |
| FMR LLC | 6.80% | 3.02M | 13G | May 6, 2026 ↗ |
| Aaron Cowenincl. Averill Master Fund, Ltd., Suvretta Capital Management, LLC | 6.10% | 2.04M | 13G | Dec 4, 2024 ↗ |
| Ting Jiaincl. Octagon Capital Advisors LP, Octagon Investments Master Fund LP +2 more | 5.90% | 1.98M | 13G | Oct 11, 2024 ↗ |
| BlackRock, Inc. | 5.60% | 2.32M | 13G | Jan 21, 2026 ↗ |
| HBM Healthcare Investments (Cayman) Ltd. | 5.40% | 2.20M | 13G | Oct 15, 2025 ↗ |
| Sofinnova Management XI, L.P. (“SM XI LP”)incl. Sofinnova Management XI, L.L.C. (“SM XI LLC”), Dr. James I. Healy (“Healy”) +2 more | 5.10% | 1.70M | 13G | Nov 12, 2024 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Hillhouse Investment Management, Ltd. | 10 percent owner | 3.93M | 8.44% | Feb 3, 2026 |
| Robin LaChapelle | officer: Chief Operating Officer | 521.1K | 1.12% | Jul 15, 2025 |
1 ten-percent owner holds 3.93M shares by Form 4 — the 13D/G table above shows that stake, the figure above counts officers and directors only · 6 people have not refiled in the last 18 months (3.45M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Dec 10, 2025 | Hillhouse Investment Management, Ltd.10 percent owner | Sale | 555,555 | $23.37 | 3,929,117 |
CongressHouse and Senate disclosures
Not reported.